Gabriella Miller Kids First Research Act 2.0

Gabriella Miller Kids First Research Act 2.0

This bill reauthorizes through FY2028 a pediatric disease research initiative within the National Institutes of Health (NIH) and requires the NIH to coordinate pediatric research activities to avoid duplicative efforts. Additionally, the Department of Health and Human Services must report to Congress about research funded through the initiative.

The Gabriella Miller Kids First Research Act 2.0, also known as Bill 118 hr 3391, is a piece of legislation introduced in the US Congress. This bill aims to prioritize funding for pediatric medical research through the National Institutes of Health (NIH). It builds upon the original Gabriella Miller Kids First Research Act, which was passed in 2014.

The main goal of this legislation is to allocate $50 million annually for the next 10 years towards pediatric research initiatives. This funding will specifically focus on childhood cancers, rare genetic disorders, and other pediatric diseases. By prioritizing research in these areas, the bill aims to improve treatments and outcomes for children facing serious health challenges.

In addition to funding pediatric research, the Gabriella Miller Kids First Research Act 2.0 also establishes a new advisory board to oversee the allocation of funds and ensure that research efforts are effectively targeting the most pressing needs in pediatric medicine. This board will consist of experts in the field of pediatric research, as well as representatives from patient advocacy groups and other stakeholders. Overall, the Gabriella Miller Kids First Research Act 2.0 is a bipartisan effort to support and advance pediatric medical research in the United States. By providing dedicated funding and oversight, this legislation aims to make significant strides in improving the health and well-being of children facing serious illnesses.